BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 28427176)

  • 1. Metronomic regimen as an effective treatment for aggressive T-LGL leukemia with central nervous system infiltration: clinical experience and review of literature.
    Liu Y; Fan L; Zhao H; Xu W; Li J
    Oncotarget; 2017 May; 8(19):32292-32297. PubMed ID: 28427176
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Aggressive T-cell large granular lymphocyte leukemia: a case report and review of the literature.
    Alekshun TJ; Tao J; Sokol L
    Am J Hematol; 2007 Jun; 82(6):481-5. PubMed ID: 17205534
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Unusual immunophenotype of T-cell large granular lymphocytic leukemia: report of two cases.
    Rabade N; Mansukhani D; Khodaiji S; Padte B; Bhave A; Tembhare P; Subramanian PG; Sehgal K
    Indian J Pathol Microbiol; 2015; 58(1):108-12. PubMed ID: 25673609
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Donor-Derived T-Cell Large Granular Lymphocytic Leukemia in a Patient With Peripheral T-Cell Lymphoma.
    Hidalgo Lopez JE; Yabe M; Carballo-Zarate AA; Wang SA; Jorgensen JL; Ahmed S; Lee J; Li S; Schlette E; McDonnell T; Miranda RN; Medeiros LJ; Bueso-Ramos CE; Yin CC
    J Natl Compr Canc Netw; 2016 Aug; 14(8):939-44. PubMed ID: 27496109
    [TBL] [Abstract][Full Text] [Related]  

  • 5. T-cell large granular lymphocytic (T-LGL) leukemia: a single institution experience.
    Sretenovic A; Antic D; Jankovic S; Gotic M; Perunicic-Jovanovic M; Jakovic L; Mihaljevic B
    Med Oncol; 2010 Jun; 27(2):286-90. PubMed ID: 19306076
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Belinostat in Relapsed/Refractory T-Cell Large Granular Lymphocyte Leukemia.
    Poh C; Arora M; Ghuman S; Tuscano J
    Acta Haematol; 2021; 144(1):95-99. PubMed ID: 32348994
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chronic myelogenous leukemia presenting with central nervous system infiltration, successfully treated with central nervous system-directed chemotherapy followed by allogeneic stem cell transplantation.
    Chiba A; Toya T; Mizuno H; Tokushige J; Nakamura F; Nakazaki K; Kurokawa M
    Int J Hematol; 2018 Dec; 108(6):640-646. PubMed ID: 30078165
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Single-center Series of Bone Marrow Biopsy-Defined Large Granular Lymphocyte Leukemia: High Rates of Sustained Response to Oral Methotrexate.
    Munir T; Bishton MJ; Carter I; McMillan A; O'Connor S; Sovani V; Haynes AP; Fox CP
    Clin Lymphoma Myeloma Leuk; 2016 Dec; 16(12):705-712. PubMed ID: 27640075
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Therapeutic management of central nervous system lymphomas in a single hematological institute].
    Iványi JL; Marton E; Plander M; Gyánó G; Czumbil L; Tóth C
    Orv Hetil; 2009 Oct; 150(42):1937-44. PubMed ID: 19812012
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of relapsed aggressive lymphomas: regimens with and without high-dose therapy and stem cell rescue.
    Hagemeister FB
    Cancer Chemother Pharmacol; 2002 May; 49 Suppl 1():S13-20. PubMed ID: 12042984
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical, morphologic, immunophenotypic, and molecular cytogenetic assessment of CD4-/CD8-γδ T-cell large granular lymphocytic leukemia.
    Chen YH; Chadburn A; Evens AM; Winter JN; Gordon LI; Chenn A; Goolsby C; Peterson L
    Am J Clin Pathol; 2011 Aug; 136(2):289-99. PubMed ID: 21757603
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Hepatocellular failure revealing T-cell large granular lymphocyte leukemia: Morocco case study and literature review].
    Benmoussa A; Oussaih L; Tazi I
    Pan Afr Med J; 2019; 34():119. PubMed ID: 31934260
    [TBL] [Abstract][Full Text] [Related]  

  • 13. T cell large granular lymphocyte leukemia associated with rheumatoid arthritis and neutropenia.
    Shah A; Diehl LF; St Clair EW
    Clin Immunol; 2009 Aug; 132(2):145-52. PubMed ID: 19394280
    [TBL] [Abstract][Full Text] [Related]  

  • 14. T-cell large granular lymphocyte leukemia transfomation into aggressive T-cell lymphoma: a report of two cases with molecular characterization.
    Belhadj M; Mansour D; Kaltenbach S; Deau-Fischer B; Franchi P; Tamburini J; Chapuis N; Damotte D; Kosmider O; Burroni B; Bouscary D
    Haematologica; 2019 Mar; 104(3):e117-e120. PubMed ID: 30573508
    [No Abstract]   [Full Text] [Related]  

  • 15. Clinical features and treatment outcomes in patients with T-cell large granular lymphocytic leukemia: A single-institution experience.
    Zhu Y; Gao Q; Hu J; Liu X; Guan D; Zhang F
    Leuk Res; 2020 Mar; 90():106299. PubMed ID: 32035354
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prednisone, etoposide, procarbazine, and cyclophosphamide (PEP-C) oral combination chemotherapy regimen for recurring/refractory lymphoma: low-dose metronomic, multidrug therapy.
    Coleman M; Martin P; Ruan J; Furman R; Niesvizky R; Elstrom R; George P; Kaufman TP; Leonard JP
    Cancer; 2008 May; 112(10):2228-32. PubMed ID: 18338745
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Large granular lymphocyte leukemia].
    Lazaro E; Caubet O; Menard F; Pellegrin JL; Viallard JF
    Presse Med; 2007 Nov; 36(11 Pt 2):1694-700. PubMed ID: 17596907
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Very long-lasting remission of refractory T-large granular lymphocytes leukemia and myeloma by lenalidomide treatment.
    Pelliccia S; Di Napoli A; Naso V; Alma E; Rebecchini C; Cox MC
    Eur J Haematol; 2013 Aug; 91(2):183-6. PubMed ID: 23692265
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intensive, very short-term chemotherapy for advanced Burkitt's lymphoma in children.
    Spreafico F; Massimino M; Luksch R; Casanova M; Cefalo GS; Collini P; Ferrari A; Polastri D; Terenziani M; Gasparini M; Fossati-Bellani F
    J Clin Oncol; 2002 Jun; 20(12):2783-8. PubMed ID: 12065554
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Salvage chemoimmunotherapy with rituximab, ifosfamide and etoposide (R-IE regimen) in patients with primary CNS lymphoma relapsed or refractory to high-dose methotrexate-based chemotherapy.
    Mappa S; Marturano E; Licata G; Frezzato M; Frungillo N; Ilariucci F; Stelitano C; Ferrari A; Sorarù M; Vianello F; Baldini L; Proserpio I; Foppoli M; Assanelli A; Reni M; Caligaris-Cappio F; Ferreri AJ
    Hematol Oncol; 2013 Sep; 31(3):143-50. PubMed ID: 23161567
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.